Rate and risk factors of venous thromboembolism during neoadjuvant chemotherapy for advanced ovarian cancer: a retrospective analysis from a referral center.

With advanced ovarian cancer receiving neoadjuvant chemotherapy are at increased risk of venous thromboembolism, although the reported incidence, risk factors, and its impact on the timing of interval debulking surgery remain heterogeneous.

This study evaluates the rate and predictors of venous thromboembolism during neoadjuvant chemotherapy, its effect on surgical timing, and contextualizes the findings through a targeted narrative review of the literature.